Marburg, Germany

Stefan Knapp



Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 114(Granted Patents)


Location History:

  • Marburg-Wehrshausen, DE (1998 - 2004)
  • Marburg, DE (1992 - 2010)

Company Filing History:


Years Active: 1992-2010

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Innovations in HIV Research by Stefan Knapp

Introduction

Stefan Knapp, based in Marburg, Germany, is a prominent inventor with an impressive portfolio of 23 patents. His work primarily focuses on advancements in the field of immunology, specifically related to the human immunodeficiency virus (HIV). Knapp's innovative contributions have significantly impacted diagnostic methods and potential treatment options for HIV.

Latest Patents

Among Knapp's latest patents is a groundbreaking invention titled "Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKLIS." This patent describes immunologically active peptides derived from a novel immunodeficiency virus, MVP5180/91. These peptides are crucial for developing diagnostic compositions that can detect antibodies against retroviruses associated with immune deficiencies. Furthermore, the patent outlines a kit that contains these immunologically active peptides, along with methods for immunizing mammals against HIV infection.

Another notable patent is centered around a retrovirus from the HIV type O, designated MVP-2901/94. This invention includes the deposition of the virus with the European Collection of Animal Cell Cultures (ECACC) and details its characteristic antigens. These antigens are essential for detecting antibodies related to immunodeficiency diseases, alongside partial DNA and amino acid sequences of the virus.

Career Highlights

Stefan Knapp has had a commendable career, prominently associated with companies such as Dade Behring Marburg GmbH and Behring Diagnostics GmbH. His tenure in these organizations has enabled him to translate his groundbreaking research into practical applications that advance the field of immunology.

Collaborations

Throughout his career, Knapp has worked alongside notable colleagues, including Hans-Peter Hauser and Lutz G. Guertler. These collaborations have fostered an environment of innovation and discovery, further enhancing the impact of their collective research efforts.

Conclusion

Stefan Knapp's work exemplifies the dedication to innovation in HIV research. His 23 patents reflect his commitment to developing diagnostic tools and therapeutic options that address the complexities of HIV and immunodeficiency diseases. With his collaborative spirit and significant contributions, Knapp continues to play a vital role in the ongoing battle against HIV, showcasing how innovation can pave the way for improved health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…